Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 06:59:21 2026-09-08 am EDT			5-day change	1st Jan Change
58.68 ^EUR	-0.13%		-2.25%	-7.64%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.49B		BBB
ELI LILLY AND COMPANY	1,024B		A
JOHNSON & JOHNSON	663B	-	BBB	-	-
ABBVIE INC.	453B		AAA		-
ROCHE HOLDING AG	349B		AA
NOVARTIS AG	295B		AAA
ASTRAZENECA PLC	253B		A
AMGEN INC.	236B		A
NOVO NORDISK A/S	206B		BBB
GILEAD SCIENCES, INC.	187B		AA
PFIZER INC.	162B		A
VERTEX PHARMACEUTICALS INCORPORATED	138B		AA
BRISTOL-MYERS SQUIBB COMPANY	136B		A
SANOFI	105B		A
GSK PLC	99.72B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.01B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	59.8B		AA
BAYER AG	55.64B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.39B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.37B		-
Average	229.31B		AA
Weighted average by Cap.			AA